Background illustration for clinical trials search

Paid Clinical Trials Birmingham

Discover 901 paid clinical trials in Birmingham, Alabama. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults

for
Asthma
Location: Birmingham AL, Albany GA, Owensboro KY,
Sponsor: Enveda Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT07301255

Phase 2, Recruiting

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

for
Relapsing Multiple Sclerosis, Multiple Sclerosis
Location: Birmingham AL, Cullman AL, Huntsville AL, Smyrna GA,
Sponsor: TG Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06433752

Recruiting

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

for
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis,
Location: Birmingham AL, Marietta GA, Dalton GA, Chattanooga TN,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18 - 70+

Code: NCT06318169

Phase 3, Recruiting

A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions

for
Narcolepsy Type 1
Location: Birmingham AL, Atlanta GA, Gainesville GA, Columbia SC,
Sponsor: Takeda

Sex: All

Age: 16 - 70

Code: NCT05816382

Phase 2, Phase 3, Recruiting

A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in Participants With Narcolepsy or IH

for
Narcolepsy, Idiopathic Hypersomnia
Location: Birmingham AL, Nashville TN, Rincon GA, Denver NC,
Sponsor: Jazz Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07625280

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

for
Non-muscle Invasive Bladder Cancer
Location: Homewood AL, Nashville TN, Memphis TN, Little Rock AR,
Sponsor: Protara Therapeutics

Sex: All

Age: 18+

Code: NCT05951179

Phase 2, Recruiting

Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.

for
Hematuria - Cause Not Known
Location: Homewood AL, Nashville TN, Mobile AL, Dayton OH,
Sponsor: Pacific Edge Limited

Sex: All

Age: 18 - 70+

Code: NCT06394869

Recruiting

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

for
Prostate Cancer
Location: Homewood AL, Chattanooga TN, Athens GA, Metairie LA,
Sponsor: Novartis Pharmaceuticals

Sex: Male

Age: 18 - 70+

Code: NCT06855277

Phase 3, Recruiting

A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer

for
Upper Urinary Tract Urothelial Carcinoma, Urothelial Carcinoma
Location: Homewood AL, Arkansas City AR, Charlotte NC,
Sponsor: UroGen Pharma Ltd.

Sex: All

Age: 18+

Code: NCT06774131

Phase 3, Recruiting

Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer

for
Low-grade NMIBC, FGFR Gene Amplification, FGFR Gene Alterations,
Location: Homewood AL, Nashville TN, Germantown TN,
Sponsor: Tyra Biosciences, Inc

Sex: All

Age: 18+

Code: NCT06995677

Phase 2, Recruiting

A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence

for
Narcolepsy Type 1, Narcolepsy Type 2
Location: Birmingham AL, Atlanta GA, Stockbridge GA, Flowood MS,
Sponsor: Centessa Pharmaceuticals (UK) Limited

Sex: All

Age: 18 - 70

Code: NCT07598708

Phase 2, Phase 3, Recruiting

A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe Eczema

for
Atopic Dermatitis
Location: Birmingham AL, Marietta GA, Macon GA, Memphis TN,
Sponsor: Pfizer

Sex: All

Age: 12+

Code: NCT07783425

Phase 3, Recruiting

Phase 2/3 Efficacy and Safety of PP405 in Adult Males

for
Androgenetic Alopecia
Location: Birmingham AL, Atlanta GA, Smyrna TN, Knoxville TN,
Sponsor: Pelage Pharmaceuticals, Inc.

Sex: Male

Age: 18 - 55

Code: NCT07819435

Phase 2, Phase 3, Recruiting

A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis

for
Atopic Dermatitis, Atopic, Dermatitis, Dermatitis, Atopic,
Location: Birmingham AL, Bryant AR, Clarksville IN,
Sponsor: Apollo Therapeutics Ltd

Sex: All

Age: 18 - 65

Code: NCT07599813

Phase 2, Recruiting
New

A Study to Learn About Berobenatide Given Once Weekly in Adults With Knee Osteoarthritis and Overweight or Obesity With or Without Type 2 Diabetes (VESPER-OA 2)

for
Obesity, Overweight and/or Obesity, Knee Osteoarthritis,
Location: Birmingham AL
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07915609

Phase 3, Recruiting

NuShield in Surgical Peroneal Tendon Repair

for
Tendon Injuries, Tendinopathy
Location: Birmingham AL, Aurora CO
Sponsor: NuTech Medical, Inc

Sex: All

Age: 18 - 60

Code: NCT03828916

Recruiting

A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Chronic Low Back Pain

for
Chronic Pain, Low Back Pain
Location: Birmingham AL, Woodstock GA, New Orleans LA, Ocala FL,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07641504

Phase 2, Recruiting

A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Osteoarthritis Pain

for
Osteoarthritis, Knee, Chronic Pain
Location: Birmingham AL, Woodstock GA, New Orleans LA, Ocala FL,
Sponsor: Eli Lilly and Company

Sex: All

Age: 40+

Code: NCT07641517

Phase 2, Recruiting

FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer

for
Ras-mutated Metastatic Colorectal Cancer, mCRC,
Location: Homewood AL, Atlanta GA, St Louis MO, Cincinnati OH,
Sponsor: Oncolytics Biotech

Sex: All

Age: 18+

Code: NCT07446322

Phase 2, Recruiting

A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)

for
Non-small Cell Lung Cancer
Location: Birmingham AL, Savannah GA, Roanoke VA, Lafayette IN,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07190248

Phase 3, Recruiting